Citations

Clear

4 citation(s) found for "Lewis-Brinkman, Sean".

CD98hc marks a precursor of human stem cell-derived alpha cells primed for functional maturation
Lewis-Brinkman, Sean , Salomon, Tiana, Knofczynski, Kyle R , Duffy, Caden, Peterson, Quinn P.

Mayo Clinic

Frontiers in Endocrinology | September 28, 2026 | Volume: 17 | Issue: No issue available | Pages: No page available

10.3389/fendo.2026.1923474 | PMID 42865487 Get It

Introduction Pluripotent stem cell-derived alpha cells (SC-α cells) represent a promising component of next-generation cell therapies designed to more fully recapitulate human islet function; however, heterogeneity and the presence of undesired side populations limit their functional maturity and therapeutic potential. Here, we identify the cell surface protein CD98hc (SLC3A2), that when highly expressed in precursor cells, is associated with differentiation toward a more transcriptionally and functionally mature population of human SC-α cells. Methods Directed differentiation was used to generate SC-α cells from pluripotent stem cells, which were assessed via single cell RNA sequencing, flow cytometry, and immunofluorescence imaging. Following magnetic activated cell sorting (MACS) of CD98hc enriched precursors, SC-α cell function was assessed using glucose stimulated glucagon secretion (GSGS). Results We show that CD98hc is upregulated in SC-α cells expressing high levels of genes known to play important roles in α cell identity and function, and that CD98hc expression is elevated at the pre-α precursor stage relative to non–α cell populations. We demonstrate that magnetic enrichment of CD98hc⁺ pre-α cells derived from multiple pluripotent stem cell lines selectively increases the proportion of the highest CD98hc expressing glucagon-copositive precursors while depleting multiple undesired side populations, including somatostatin-positive and SOX9-positive cells. Although total α cell yield equalizes following complete differentiation, SC-α cells derived from high-CD98hc enriched precursors exhibit significantly enhanced glucose-responsive glucagon secretion compared to sham-sorted controls, indicating improved functional maturation of this precursor population. Discussion Together, these findings establish that high expression levels of CD98hc marks a functionally superior α cell precursor, that enrichment at the precursor stage can bias differentiation toward higher functional α cell output, that stem cell-derived α cell populations harbor intrinsic functional heterogeneity, and that selective targeting of precursor populations represents a generalizable strategy to improve the quality and performance of stem cell-derived endocrine cell products.
Clinical-grade cryopreservation unlocks transplant-ready human pancreatic and stem cell–derived islets for diabetes therapy
Guo, Zongqi, Khashim, Zenith , Knofczynski, Kyle, Tobolt, Diane, Shivakumar, Sharath Belame, Rangarajan, Parthasarathy , Herman, Adam , Abdulla, Muhamad, Tran, Anna , Fisher, Benjamin , Salomon, Tiana, Lewis-Brinkman, Sean , Steinhoff, Magie, Balamurugan, Appakalai N. , Hering, Bernhard J. , Bischof, John, Finger, Erik B. , Rao, Joseph Sushil , Knofczynski, Kyle R , Fisher, Benjamin J., Etheridge, Michael L. , Ramachandran, Sabarinathan , Peterson, Quinn P. , Bischof, John C , Finger, Erik B.

Mayo Clinic

No container title available | April 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.25.720819 | PMID 42094508 Get It

ABSTRACT Pancreatic islet transplantation can restore endogenous insulin production and offers a potential cure for diabetes, but its clinical impact has been limited by the inability to preserve large numbers of functional islets for timely use. Cryopreservation could provide an on-demand supply, yet conventional methods cause ice formation, cell injury, and loss of insulin secretion. We developed CryoMesh, a vitrification platform that combines a low-toxicity cryoprotectant with a thermally conductive, biocompatible mesh to enable ultra-rapid cooling and rewarming for ice-free cryopreservation. This approach supports long-term, clinical-scale preservation of both human pancreatic and stem cell–derived islets while maintaining viability, architecture, mitochondrial integrity, and glucose-responsive insulin secretion. Human islets preserved for up to one year restored normoglycemia in diabetic mice, with complete recovery of function and no increase in immunogenicity or loss of potency. The combination of high viability, recovery, and functional preservation at clinical scale has not been achieved previously. By decoupling islet isolation and manufacture from transplantation, CryoMesh enables extended quality, potency, and safety testing, cost-effective batch production, and global banking and distribution. These capabilities remove a major barrier to curative cell therapy for diabetes and establish a generalizable strategy for preserving complex multicellular therapeutics. One Sentence Summary A clinical scale vitrification platform enables long-term banking of human pancreatic and stem cell–derived islets for transplantation.
Disruption of Cell-Adhesion Signaling Resolves Unwanted Progenitor Specification in Stem Cell-Derived α and β Cell Grafts
Knofczynski, Kyle R , Law, Ethan, Lewis-Brinkman, Sean , Khashim, Zenith , Schornack, Anna Marie R , Shrestha, Swikriti , Jennings, Lauren T. , Peterson, Quinn P. , Law, Ethan W. , Jennings, Lauren , Law, Ethan W , Schornack, Anna Marie , Peterson, Quinn

Mayo Clinic

Cells | February 9, 2026 | Volume: 15 | Issue: 4 | Pages: 314

10.3390/cells15040314 | PMID 41744757 Get It

Directed differentiation protocols have recently been developed to produce stem cell-derived α (SC-α) cells as a potential component of a complete cell-based therapy for T1D, to complement the more widely studied stem cell-derived β (SC-β) cells. Differentiation protocols for SC-β cells produce off-target cell populations implicated in the development of outgrowths in SC-β cell grafts, but outgrowths from SC-α cells have not been explored. This study identifies that engrafted SC-α cells generate outgrowths of similar composition to SC-β cell outgrowths. Both cell types share outgrowth-driving populations marked by SOX9, CDX2, or SOX2. Single-cell RNA sequencing was used to reveal an enrichment in cell-adhesion signaling events in outgrowth-driving populations. Small-molecule inhibition of the Notch pathway was insufficient to disrupt all three outgrowth-driving populations. A comprehensive disruption of cell-adhesion signaling via single-cell dispersion and reaggregation is found to reduce the outgrowth propensity in engrafted SC-α and SC-β cells. Together, these results suggest that disrupting residual progenitor cells with SC-α and SC-β cell clusters can enhance the safety profile of these cell therapy products for T1D therapy.
Lipotoxicity Induces β-cell Small Extracellular Vesicle–Mediated β-cell Dysfunction in Male Mice
Roy, Abhishek , Hoff, Alexandra, Ariyaratne, Gallage, Tahawi, M H D Noor, Rajagopalan, Kamalnath Sankaran, Brown, Matthew , Omori, Kazuno , Lewis-Brinkman, Sean , Nguyen, Thanh, Soto-González, Alondra , Matveyenko, Aleksey V. , Javeed, Naureen , Her, Tracy K. , Gutiérrez, Roberto-León, Peterson, Quinn P. , Javeed, Naureen , Roy, Abhishek, Gutiérrez, Roberto-León, TAHAWI, MHD NOOR

Mayo Clinic

Endocrinology | April 3, 2025 | Volume: 166 | Issue: 5 | Pages: No page available

10.1210/endocr/bqaf067 | PMID 40179251 Get It

Abstract Chronically elevated circulating excess free fatty acids (ie, lipotoxicity) is a pathological process implicated in several metabolic disorders, including obesity-driven type 2 diabetes (T2D). Lipotoxicity exerts detrimental effects on pancreatic islet β-cells by reducing glucose-stimulated insulin secretion (GSIS), altering β-cell transcriptional identity, and promoting apoptosis. While β-cell-derived small extracellular vesicles (sEV) have been shown to contribute to β-cell failure in T2D, their specific role in lipotoxicity-mediated β-cell failure remains to be elucidated. In this work, we demonstrate that lipotoxicity enhances the release of sEVs from β-cells, which exhibit altered proteomic and lipidomic profiles. These palmitate (PAL)-exposed extracellular vesicles (EVs) induce β-cell dysfunction in healthy mouse and human islets and trigger significant islet transcriptional changes, including the upregulation of genes associated with the TGFβ/Smad3 pathway, as noted by RNA sequencing. Importantly, pharmacological inhibition of the TGFβI/II receptor improved PAL EV-induced β-cell dysfunction, underscoring their involvement in activating the TGFβ/Smad3 pathway during this process. We have comprehensively characterized lipotoxic β-cell sEVs and implicated their role in inducing β-cell functional failure in T2D. These findings highlight potential avenues for therapeutic interventions targeting sEV-mediated pathways to preserve β-cell health in metabolic disorders.